Evercore ISI analyst Robert Ottenstein raised the firm’s price target on Colgate-Palmolive to $91 from $85 and keeps an Outperform rating on the shares following the company’s Q1 report, arguing that Colgate’s volume recovery in Q1 "indicates that its pricing actions "are sticking." The firm continues to argue that Colgate-Palmolive "isn’t just another ‘margin recovery’ story" in home and personal care, but "a bet on Colgate becoming a faster and durable grower."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CL:
- Colgate-Palmolive price target raised to $85 from $80 at BofA
- Colgate-Palmolive price target raised to $81 from $76 at Wells Fargo
- Colgate-Palmolive price target raised to $92 from $88 at Citi
- Colgate-Palmolive Rises on Q1 Showing
- Unusual call flow in option market yesterday
Questions or Comments about the article? Write to editor@tipranks.com